← back to search

Suzanne L. Wolden

Kettering University · US
🔎 Find collaborators in Pulmonary and Respiratory Medicine · Otorhinolaryngology →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Pulmonary and Respiratory Medicine · Otorhinolaryngology
Research interest
Research interests include Sarcoma Diagnosis and Treatment, Head and Neck Cancer Studies, Neuroblastoma Research and Treatments, and Glioma Diagnosis and Treatment.
h-index
75
citations
18,016
works
514
NIH funding
primary concept
Medicine
email

Recent publications

Proton Craniospinal Irradiation for Patients With Leptomeningeal Metastasis
JAMA Oncology 2025cited by 11position: middledoi
Radiation Therapy Dose Escalation Failed to Improve Local Control for Intermediate-Risk Rhabdomyosarcoma on ARST1431: A Report From the Children’s Oncology Group
International Journal of Radiation Oncology*Biology*Physics 2025cited by 5position: contributordoi
High-Dose-Rate Brachytherapy for Vaginal Rhabdomyosarcoma (RMS): Lessons Learned at a Single Institution.
2025cited by 0position: contributordoi
Impact of risk-based therapy on late morbidity and mortality in neuroblastoma survivors: a report from the Childhood Cancer Survivor Study
JNCI Journal of the National Cancer Institute 2024cited by 11position: middledoi
Hypofractionated re-irradiation for diffuse intrinsic pontine glioma.
2024cited by 8position: contributordoi
Whole Lung Irradiation in Rhabdomyosarcoma With Lung Metastases: A Report From the Soft Tissue Sarcoma Committee of the Children's Oncology Group.
2024cited by 3position: contributordoi
Ovarian function in female survivors of high-risk neuroblastoma.
2024cited by 3position: contributordoi
Intraoperative radiation therapy for pediatric sarcomas and other solid tumors.
2024cited by 2position: contributordoi
Outcomes for patients with perineal and perianal rhabdomyosarcoma: A report from the Children's Oncology Group Soft Tissue Sarcoma Committee.
2024cited by 1position: contributordoi
Craniospinal irradiation and/or intraventricular radioimmunotherapy after high-dose chemotherapy and autologous stem cell rescue in patients with CNS retinoblastoma-Safety and outcomes.
2024cited by 0position: contributordoi
Local treatment of rhabdomyosarcoma of the female genital tract: Expert consensus from the Children's Oncology Group, the European Soft-Tissue Sarcoma Group, and the Cooperative Weichteilsarkom Studiengruppe.
2023cited by 28position: contributordoi
Long-Term Morbidity and Mortality Among Survivors of Neuroblastoma Diagnosed During Infancy: A Report From the Childhood Cancer Survivor Study.
2023cited by 10position: contributordoi
Extremity Rhabdomyosarcoma-An Integrated Clinicopathologic and Genomic Study to Improve Risk Stratification.
2023cited by 5position: contributordoi
Clinical outcomes of pediatric patients receiving multimodality treatment of second central nervous system relapse of neuroblastoma.
2023cited by 3position: contributordoi
Children's Oncology Group's 2023 blueprint for research: Radiation oncology.
2023cited by 2position: contributordoi
Lack of complete response pretransplant is not associated with inferior overall survival for stage 4a metastatic retinoblastoma.
2023cited by 1position: contributordoi
Randomized Phase II Trial of Proton Craniospinal Irradiation Versus Photon Involved-Field Radiotherapy for Patients With Solid Tumor Leptomeningeal Metastasis.
2022cited by 99position: contributordoi
Creating a data commons: The INternational Soft Tissue SaRcoma ConsorTium (INSTRuCT)
Pediatric Blood & Cancer 2022cited by 27position: middledoi
Local control of parameningeal rhabdomyosarcoma: An expert consensus guideline from the International Soft Tissue Sarcoma Consortium (INSTRuCT)
Pediatric Blood & Cancer 2022cited by 22position: lastdoi
Creating a data commons: The INternational Soft Tissue SaRcoma ConsorTium (INSTRuCT).
2022cited by 21position: contributordoi
Local control of parameningeal rhabdomyosarcoma: An expert consensus guideline from the International Soft Tissue Sarcoma Consortium (INSTRuCT).
2022cited by 18position: contributordoi
Second cancer risk in childhood cancer survivors treated with intensity-modulated radiation therapy: An updated analysis of more than 10 years of follow-up.
2022cited by 15position: contributordoi
Impact of Risk-Adapted Therapy for Pediatric Hodgkin Lymphoma on Risk of Long-Term Morbidity: A Report From the Childhood Cancer Survivor Study
Journal of Clinical Oncology 2021cited by 40position: middledoi
Rhabdomyosarcoma
Pediatric Blood & Cancer 2021cited by 40position: middledoi
Rhabdomyosarcoma.
2021cited by 28position: contributordoi
Synovial Sarcoma in Children, Adolescents, and Young Adults: A Report From the Children's Oncology Group ARST0332 Study.
2021cited by 27position: contributordoi
Impact of Risk-Adapted Therapy for Pediatric Hodgkin Lymphoma on Risk of Long-Term Morbidity: A Report From the Childhood Cancer Survivor Study.
2021cited by 27position: contributordoi
Alveolar rhabdomyosarcoma with regional nodal involvement: Results of a combined analysis from two cooperative groups.
2021cited by 24position: contributordoi
Prognostic value of baseline metabolic tumor volume in children and adolescents with intermediate-risk Hodgkin lymphoma treated with chemo-radiation therapy: FDG-PET parameter analysis in a subgroup from COG AHOD0031.
2021cited by 15position: contributordoi
Subsequent malignant neoplasms among children with Hodgkin lymphoma: a report from the Children's Oncology Group.
2021cited by 14position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

· 33 papers (2019–2025)Douglas S. Hawkins · Seattle Children's Hospital8 papers (2014–2022)Gianni Bisogno · St. Jude Children's Research Hospital7 papers (2018–2023)Susan A. Smith · The University of Texas MD Anderson Cancer Center6 papers (2019–2024)David A. Rodeberg · University of Kentucky6 papers (2014–2022)Leslie L. Robison · Datar Cancer Genetics (India)6 papers (2019–2024)Tara O. Henderson · Northwestern University5 papers (2021–2024)Danielle N. Friedman · National Coalition for Cancer Survivorship5 papers (2019–2024)Sheri L. Spunt · Stanford University5 papers (2014–2021) · 4 papers (2016–2022)Dana L. Casey · American Society for Radiation Oncology4 papers (2022–2024)Kathryn Tringale · University of California San Diego4 papers (2022–2024)Shakeel Modak · Asian Institute of Gastroenterology4 papers (2020–2024)Douglas S. Hawkins · Seattle University4 papers (2020–2023)Louis S. Constine · University of Rochester Medical Center4 papers (2016–2021)Lynn Million · Stanford University4 papers (2014–2020)Paul C. Nathan · University of Toronto4 papers (2021–2024)David M. Parham · The University of Texas Southwestern Medical Center4 papers (2014–2020)Andrea Hayes‐Jordan · University of North Carolina at Chapel Hill4 papers (2014–2016)Leo Mascarenhas · Cedars-Sinai Medical Center4 papers (2014–2021)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Pulmonary and Respiratory Medicine · Otorhinolaryngology →